C. Pastorino

The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs

F. Zara, N. Pedemonte, L. Galietta, 2022, International journal of molecular sciences.

Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators

F. Zara, N. Pedemonte, C. Castellani, 2023, International journal of molecular sciences.

Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background.

F. Zara, N. Pedemonte, L. Galietta, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment

F. Zara, N. Pedemonte, L. Galietta, 2021, International journal of molecular sciences.

Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors

F. Zara, N. Pedemonte, S. Ravera, 2022, Cancers.

Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes

N. Pedemonte, S. Furini, F. Fava, 2022, Cells.

Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays

G. Damonte, E. Cichero, N. Pedemonte, 2022, Pharmaceuticals.